Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Samuel Masket MD

Samuel Masket MD

Clinical Professor of Ophthalmology, Geffen School of Medicine, UCLA, Los Angeles, California

Dr. Masket is Clinical Professor of Ophthalmology at the Geffen School of Medicine, UCLA.  He has served on the Board of Trustees of the American Academy of Ophthalmology and is past president of the American Society of Cataract and Refractive Surgery.  He serves as an Associate Examiner for the American Board of Ophthalmology.  Dr. Masket has published nearly 100 peer reviewed articles and 2 textbooks, he serves on the Editorial Board of several journals, and is the Consultation Section editor of the Journal of Cataract and Refractive Surgery. He has been an invited guest surgeon and named lecturer throughout the world.  Along with many named lectures he has presented the 1998 Binkhorst Medal Lecture, the 2013 Kelman Memorial Lecture at the annual meeting of AAO, and most recently the 2014 Jan G.F. Worst Lecture at the International Intra-Ocular Implant Club Meeting in Boston.

Disclosures

Dr. Masket receives grant support from Accutome, Inc and WaveTec Vision Systems, Inc. He is a consultant/advisor for Alcon Laboratories, Inc., Haag-Streit, Ocular Theraputix, PowerVision, and WaveTec. He owns patents/royalties for Haag-Streit and Morcher GmbH, and receives lecture fees from Alcon and MST Surgical. Also, he is an equity owner for Ocular Theraputix.